We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more OK
Menu Search : Valcyte

You are here:

  1. Products
  2. Infectious and autoimmune disease
  3. Valcyte
  • Home
  • About Roche
  • Products
  • Therapeutic Areas
  • Careers
  • Inside Roche Pakistan
  • Contact Us
  • en_pk

Valcyte (valganciclovir)

Valcyte works by preventing the spread of cytomegalovirus (CMV) disease, or slowing the growth of CMV. It is indicated for the treatment of CMV retinitis in adult patients with acquired immunodeficiency syndrome (AIDS), and the prevention of CMV disease in adult and paediatric solid organ transplant patients who are at risk of infection.

M-PK-00000765

Share
  • Share via email
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share on Google+
  • Share on Xing
Close
Valcyte

This information is intended for HCP only. This is a prescription based drug. Please consult your doctor if you need more information.

  • © 2023
  • 04.04.2022
  • Privacy Statement
  • Legal Statement
  • Cookie Preferences.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country.Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.